Multi-center Validation of a Hypothermia Prediction Mobile Application (APP)

April 10, 2022 updated by: Huang YuGuang, Peking Union Medical College Hospital

A Clinical Multicenter, Prospective, Observational Cohort Study to Validate a Prediction Mobile APP for Perioperative Hypothermia

There have been no fully validated tools for rapid screen of surgical patients at risk of intraoperative hypothermia. The aim of this study is to validate the performance of a previously established prediction model in estimating risk of intraoperative hypothermia using a prospective cohort before further implementation of the model. We hypothesize that the prediction model has helpful discrimination and adequate calibration [1] for clinical use.

Study Overview

Status

Recruiting

Detailed Description

This is a multicenter, prospective, observational cohort study to validate the property of a previously established mobile application (APP) [2] for estimating risk of intraoperative hypothermia. Patients scheduled for elective surgery under general anesthesia will be enrolled consecutively at 30 hospitals, which are randomly selected across China, between June, 2021 and December 2022. The total planned sample size is 3000 cases. Eligible participants will be identified, informed to sign the consent, and flagged at preoperative interview the day prior to the operation. Anesthetics and perioperative temperature management will be chosen at the discretion of the anesthesiologists without intervention. Intraoperative hypothermia risk score of each participant will be calculated by a mobile application of the predictor model [2] before surgery. A wireless axillary thermometer [3] will be used to continuously measure and record perioperative core temperature as the reference standard. All participants will be followed up until 30 days after the operation.

Study Type

Observational

Enrollment (Anticipated)

3000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • Recruiting
        • Department of Anesthesiology, Peking Union Medical College Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Participants will be selected from 30 hospitals which are randomly selected across China.

Description

Inclusion Criteria:

  • aged 18 years or older
  • undergoing elective operation with general anesthesia or combined with other anesthesia
  • operation is expected to last more than 40 minutes

Exclusion Criteria:

  • central hyperthermia (e.g., cerebrovascular disease, traumatic brain injury, cerebral operation, epilepsy or acute hydrocephalus)
  • impaired thermoregulation (e.g., neuroleptic malignant syndrome, malignant hyperthermia, or known hyperthyroidism/hypothyroidism with current thyroid dysfunction
  • infectious fever
  • core temperature ≥38.5 ℃ attributable to other causes within 3 days before surgery
  • operation with induced hypothermia (e.g. cardiopulmonary bypass)
  • unsuited for infrared tympanic thermometry or axillary temperature monitoring
  • unwilling to give signed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
occurrence of perioperative hypothermia
Time Frame: during the perioperative period, an average of 2.5 hours
core temperature (measured by wireless axillary thermometer) <36.0 ℃ at any time from admission to the preoperative holding area till discharge from post anesthesia care unit (PACU)
during the perioperative period, an average of 2.5 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
amount of blood loss and blood transfusion
Time Frame: during the operation
amount of blood loss and blood transfusion during the operation
during the operation
occurrence of shivering and thermal discomfort
Time Frame: during the perioperative period, an average of 2.5 hour
shivering and thermal discomfort occurring from admission to the preoperative holding area till discharge from post anesthesia care unit (PACU)
during the perioperative period, an average of 2.5 hour
duration of hospitalization
Time Frame: during hospitalization, an average of 10 days
time from hospital admission to hospital discharge
during hospitalization, an average of 10 days
occurrence of myocardial injury non-cardiac surgery (MINS)
Time Frame: during 3 days after the operation
(1) a non-high-sensitivity troponin T ≥30ng/L, or (2) a high-sensitivity troponin T (hsTnT) ≥65ng/L, or (3) a hsTnT of 20 to <65 ng/L with an absolute change of at least 5 ng/L, or (4) an elevation as any value above the 99th percentile upper reference limit for troponin I [4-6]
during 3 days after the operation
occurrence of surgical site infection (SSI)
Time Frame: during 30 days after the operation
definition of SSI is according to the CDC criterion in 2021 [7]
during 30 days after the operation
occurrence of death
Time Frame: during 30 days after the operation
death occurring in 30 days after the operation
during 30 days after the operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yuguang Huang, M.D., Department of Anesthesiology, Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2021

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

March 28, 2022

First Submitted That Met QC Criteria

April 10, 2022

First Posted (Actual)

April 18, 2022

Study Record Updates

Last Update Posted (Actual)

April 18, 2022

Last Update Submitted That Met QC Criteria

April 10, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HypothermiaAPP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perioperative Hypothermia

Subscribe